tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Ratios

Compare
196 Followers

Pharming Group Ratios

PHAR's free cash flow for Q4 2025 was €0.80. For the 2025 fiscal year, PHAR's free cash flow was decreased by € and operating cash flow was €0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.59 2.59 3.77 4.06 4.65
Quick Ratio
2.03 2.03 3.02 3.33 3.94
Cash Ratio
1.26 1.26 0.74 0.79 3.47
Solvency Ratio
0.06 0.06 0.02 0.02 0.12
Operating Cash Flow Ratio
0.51 0.43 -0.02 -0.22 0.38
Short-Term Operating Cash Flow Coverage
6.77 5.75 -0.42 -9.49 12.70
Net Current Asset Value
€ 65.23M€ 65.20M€ 99.52M€ 72.27M€ 56.34M
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.05 0.28 0.37 0.39
Debt-to-Equity Ratio
0.42 0.08 0.51 0.78 0.81
Debt-to-Capital Ratio
0.29 0.08 0.34 0.44 0.45
Long-Term Debt-to-Capital Ratio
0.25 0.25 0.26 0.38 0.39
Financial Leverage Ratio
1.80 1.80 1.81 2.12 2.08
Debt Service Coverage Ratio
0.71 0.34 1.00 1.46 4.52
Interest Coverage Ratio
1.33 1.06 -0.99 -0.90 3.40
Debt to Market Cap
0.08 0.08 0.12 0.18 0.15
Interest Debt Per Share
0.17 0.49 1.76 2.70 2.08
Net Debt to EBITDA
-0.95 -6.35 3.52 11.12 -1.21
Profitability Margins
Gross Profit Margin
88.23%87.90%88.09%89.72%91.46%
EBIT Margin
6.32%5.13%0.08%-2.47%9.89%
EBITDA Margin
7.49%5.13%5.49%4.03%16.31%
Operating Profit Margin
5.91%5.13%-2.90%-2.20%8.87%
Pretax Profit Margin
3.37%3.42%-2.86%-4.90%7.29%
Net Profit Margin
0.58%0.76%-3.98%-4.30%6.65%
Continuous Operations Profit Margin
0.49%0.67%-3.98%-4.30%6.65%
Net Income Per EBT
17.06%22.19%139.44%87.81%91.24%
EBT Per EBIT
57.03%66.52%98.50%222.98%82.20%
Return on Assets (ROA)
0.49%0.57%-2.96%-2.28%3.21%
Return on Equity (ROE)
0.87%1.03%-5.36%-4.82%6.68%
Return on Capital Employed (ROCE)
6.53%5.04%-2.64%-1.40%4.98%
Return on Invested Capital (ROIC)
0.92%0.97%-2.59%-1.21%4.48%
Return on Tangible Assets
0.67%0.78%-3.49%-2.69%3.90%
Earnings Yield
0.20%0.23%-1.77%-1.40%1.50%
Efficiency Ratios
Receivables Turnover
7.75 6.90 5.92 5.76 8.12
Payables Turnover
0.47 0.43 3.50 1.57 2.01
Inventory Turnover
0.77 0.70 0.64 0.44 0.41
Fixed Asset Turnover
17.69 15.74 12.76 7.33 5.25
Asset Turnover
0.85 0.75 0.74 0.53 0.48
Working Capital Turnover Ratio
2.09 1.78 1.34 1.08 0.98
Cash Conversion Cycle
-252.75 -274.94 532.02 653.18 742.73
Days of Sales Outstanding
47.08 52.92 61.62 63.41 44.97
Days of Inventory Outstanding
474.66 519.04 574.57 821.73 879.68
Days of Payables Outstanding
774.50 846.90 104.17 231.95 181.92
Operating Cycle
521.75 571.96 636.19 885.13 924.65
Cash Flow Ratios
Operating Cash Flow Per Share
0.08 0.60 -0.03 -0.26 0.27
Free Cash Flow Per Share
0.07 0.59 -0.04 -0.29 0.25
CapEx Per Share
<0.01 <0.01 0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
0.99 0.98 1.44 1.08 0.91
Dividend Paid and CapEx Coverage Ratio
69.70 66.66 -2.26 -11.82 11.36
Capital Expenditure Coverage Ratio
69.70 66.66 -2.26 -11.82 11.36
Operating Cash Flow Coverage Ratio
0.51 2.17 -0.02 -0.10 0.13
Operating Cash Flow to Sales Ratio
0.14 0.13 >-0.01 -0.07 0.11
Free Cash Flow Yield
4.56%3.91%-0.39%-2.50%2.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
494.56 440.65 -56.60 -71.20 66.58
Price-to-Sales (P/S) Ratio
3.00 3.34 2.26 3.06 4.43
Price-to-Book (P/B) Ratio
4.35 4.55 3.03 3.43 4.45
Price-to-Free Cash Flow (P/FCF) Ratio
21.92 25.55 -258.67 -40.02 44.45
Price-to-Operating Cash Flow Ratio
20.46 25.16 -373.37 -43.40 40.54
Price-to-Earnings Growth (PEG) Ratio
2.59 -3.67 -3.28 0.38 -3.92
Price-to-Fair Value
4.35 4.55 3.03 3.43 4.45
Enterprise Value Multiple
39.12 58.70 44.60 87.15 25.94
Enterprise Value
1.06B 967.84M 727.58M 860.79M 869.82M
EV to EBITDA
39.11 58.70 44.60 87.15 25.94
EV to Sales
2.93 3.01 2.45 3.51 4.23
EV to Free Cash Flow
21.39 23.05 -280.81 -45.87 42.47
EV to Operating Cash Flow
21.08 22.71 -405.33 -49.75 38.73
Tangible Book Value Per Share
0.36 3.31 2.32 2.25 1.57
Shareholders’ Equity Per Share
0.36 3.31 3.21 3.33 2.48
Tax and Other Ratios
Effective Tax Rate
0.86 0.80 -0.39 0.12 0.09
Revenue Per Share
0.55 4.50 4.31 3.73 2.49
Net Income Per Share
<0.01 0.03 -0.17 -0.16 0.17
Tax Burden
0.17 0.22 1.39 0.88 0.91
Interest Burden
0.53 0.67 -34.66 1.99 0.74
Research & Development to Revenue
0.27 0.00 0.28 0.28 0.26
SG&A to Revenue
0.17 0.00 0.31 0.33 0.30
Stock-Based Compensation to Revenue
0.03 0.00 0.04 0.04 0.03
Income Quality
3.98 17.51 0.21 1.44 1.50
Currency in EUR